{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:47Z","timestamp":1788265007978,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303022"],"award-info":[{"award-number":["82303022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372714"],"award-info":[{"award-number":["82372714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122048"],"award-info":[{"award-number":["82122048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neo.2026.101344","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:25:27Z","timestamp":1785317127000},"page":"101344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Developmentally constrained plasticity as a therapeutic vulnerability in cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Jie-Shen","family":"Xian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Xiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3222-8715","authenticated-orcid":false,"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neo.2026.101344_bib0001","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"Perez-Gonzalez","year":"2023","journal-title":"Nat. Cancer"},{"issue":"6632","key":"10.1016\/j.neo.2026.101344_bib0002","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neo.2026.101344_bib0003","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.neo.2026.101344_bib0004","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1016\/j.cell.2024.04.032","article-title":"A developmental constraint model of cancer cell states and tumor heterogeneity","volume":"187","author":"Patel","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101344_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2024.105376","article-title":"Understanding cancer from a biophysical, developmental and systems biology perspective using the landscapes-attractor model","volume":"247","author":"Grunt","year":"2025","journal-title":"Biosystems"},{"issue":"6","key":"10.1016\/j.neo.2026.101344_bib0006","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.devcel.2018.02.024","article-title":"Developmental history provides a roadmap for the emergence of tumor plasticity","volume":"44","author":"Tata","year":"2018","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.neo.2026.101344_bib0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrg.2018.9","article-title":"Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer","volume":"19","author":"Ge","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.neo.2026.101344_bib0008","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041389","article-title":"Cellular origins and lineage plasticity in cancer","volume":"14","author":"Pitarresi","year":"2024","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"issue":"6","key":"10.1016\/j.neo.2026.101344_bib0009","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.trecan.2026.02.001","article-title":"Dissecting histological transformation","volume":"12","author":"Earlie","year":"2026","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.neo.2026.101344_bib0010","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1038\/ncomms7377","article-title":"RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer","volume":"6","author":"Niederst","year":"2015","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.neo.2026.101344_bib0011","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1158\/0008-5472.CAN-10-0824","article-title":"Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma","volume":"70","author":"Ning","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0012","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1038\/s41467-024-49926-2","article-title":"Transposable elements-mediated recruitment of KDM1A epigenetically silences HNF4A expression to promote hepatocellular carcinoma","volume":"15","author":"Jing","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neo.2026.101344_bib0013","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41588-025-02081-w","article-title":"Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis","volume":"57","author":"Lim","year":"2025","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.neo.2026.101344_bib0014","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2025.09.022","article-title":"Targeting cell-state plasticity driven by FOXM1\/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinoma","volume":"84","author":"Zhang","year":"2026","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.neo.2026.101344_bib0015","article-title":"CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma","volume":"6","author":"Xu","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"579","key":"10.1016\/j.neo.2026.101344_bib0016","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb6282","article-title":"Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate","volume":"13","author":"Kong","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"8015","key":"10.1016\/j.neo.2026.101344_bib0017","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-024-07465-2","article-title":"Acquisition of epithelial plasticity in human chronic liver disease","volume":"630","author":"Gribben","year":"2024","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neo.2026.101344_bib0018","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neo.2026.101344_bib0019","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s43018-020-00154-9","article-title":"Gradient of developmental and injury-response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity","volume":"2","author":"Richards","year":"2021","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.neo.2026.101344_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trecan.2022.10.010","article-title":"Neuronal and tumourigenic boundaries of glioblastoma plasticity","volume":"9","author":"De Silva","year":"2023","journal-title":"Trends. Cancer"},{"issue":"41","key":"10.1016\/j.neo.2026.101344_bib0021","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1038\/s41388-025-03573-z","article-title":"Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer","volume":"44","author":"Chukhu","year":"2025","journal-title":"Oncogene"},{"issue":"6320","key":"10.1016\/j.neo.2026.101344_bib0022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neo.2026.101344_bib0023","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.09.005","article-title":"N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer","volume":"30","author":"Dardenne","year":"2016","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.neo.2026.101344_bib0024","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrurol.2018.22","article-title":"Cellular plasticity and the neuroendocrine phenotype in prostate cancer","volume":"15","author":"Davies","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"23","key":"10.1016\/j.neo.2026.101344_bib0025","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1158\/1078-0432.CCR-19-1423","article-title":"The role of lineage plasticity in prostate cancer therapy resistance","volume":"25","author":"Beltran","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.neo.2026.101344_bib0026","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6320","key":"10.1016\/j.neo.2026.101344_bib0027","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neo.2026.101344_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216815","article-title":"Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer","volume":"588","author":"Kanaoka","year":"2024","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.neo.2026.101344_bib0029","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","article-title":"Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance","volume":"3","author":"Deng","year":"2022","journal-title":"Nat. Cancer"},{"issue":"6611","key":"10.1016\/j.neo.2026.101344_bib0030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.neo.2026.101344_bib0031","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0032","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s43018-023-00672-2","article-title":"Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy","volume":"5","author":"Li","year":"2024","journal-title":"Nat. Cancer"},{"issue":"24","key":"10.1016\/j.neo.2026.101344_bib0033","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.devcel.2023.11.008","article-title":"A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas","volume":"58","author":"Falvo","year":"2023","journal-title":"Dev. Cell"},{"issue":"8110","key":"10.1016\/j.neo.2026.101344_bib0034","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41586-026-10258-4","article-title":"Epigenetic memory of colitis promotes tumour growth","volume":"652","author":"Nagaraja","year":"2026","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neo.2026.101344_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cell.2022.12.027","article-title":"Loss of epigenetic information as a cause of mammalian aging","volume":"186","author":"Yang","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neo.2026.101344_bib0036","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s43018-025-01003-3","article-title":"Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer","volume":"6","author":"Antonucci","year":"2025","journal-title":"Nat. Cancer"},{"issue":"10","key":"10.1016\/j.neo.2026.101344_bib0037","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc.2017.68","article-title":"Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence","volume":"17","author":"Giroux","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"7986","key":"10.1016\/j.neo.2026.101344_bib0038","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","article-title":"Epigenetic regulation during cancer transitions across 11 tumour types","volume":"623","author":"Terekhanova","year":"2023","journal-title":"Nature"},{"issue":"7782","key":"10.1016\/j.neo.2026.101344_bib0039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0041","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug-tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.neo.2026.101344_bib0042","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","article-title":"ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer","volume":"12","author":"Jeselsohn","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0043","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41467-023-35961-y","article-title":"Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer","volume":"14","author":"Chmielecki","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101344_bib0044","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST20230426","article-title":"Bivalent chromatin: a developmental balancing act tipped in cancer","volume":"52","author":"Glancy","year":"2024","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.neo.2026.101344_bib0046","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.neo.2026.101344_bib0047","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1158\/0008-5472.CAN-20-0672","article-title":"EZH2 regulates pancreatic cancer subtype identity and tumor progression via transcriptional repression of GATA6","volume":"80","author":"Patil","year":"2020","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101344_bib0048","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An evolutionarily conserved function of Polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.neo.2026.101344_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70335","article-title":"Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer","volume":"15","author":"Liang","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-021-00702-4","article-title":"Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma","volume":"6","author":"Xie","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0051","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1158\/0008-5472.CAN-24-0788","article-title":"LSD1 and CoREST2 potentiate STAT3 activity to promote enteroendocrine cell differentiation in mucinous colorectal cancer","volume":"85","author":"Ladaika","year":"2025","journal-title":"Cancer Res."},{"issue":"7930","key":"10.1016\/j.neo.2026.101344_bib0052","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-022-05242-7","article-title":"A cellular hierarchy in melanoma uncouples growth and metastasis","volume":"610","author":"Karras","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0053","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41568-025-00873-0","article-title":"Identification, functional insights and therapeutic targeting of EMT tumour states","volume":"26","author":"Dong","year":"2026","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2026.101344_bib0054","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s43018-024-00839-5","article-title":"Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations","volume":"5","author":"Youssef","year":"2024","journal-title":"Nat. Cancer"},{"issue":"25","key":"10.1016\/j.neo.2026.101344_bib0055","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","article-title":"Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer","volume":"184","author":"Raghavan","year":"2021","journal-title":"Cell"},{"issue":"8066","key":"10.1016\/j.neo.2026.101344_bib0056","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41586-025-08927-x","article-title":"Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer","volume":"642","author":"Pei","year":"2025","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neo.2026.101344_bib0057","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41422-023-00831-1","article-title":"An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression","volume":"33","author":"Wu","year":"2023","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.neo.2026.101344_bib0058","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/s43018-025-01053-7","article-title":"A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma","volume":"6","author":"Zhao","year":"2025","journal-title":"Nat. Cancer"},{"issue":"24","key":"10.1016\/j.neo.2026.101344_bib0059","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1016\/j.cell.2025.09.021","article-title":"CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success","volume":"188","author":"Ludin","year":"2025","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neo.2026.101344_bib0060","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.tcb.2024.01.006","article-title":"Functional analysis of cell plasticity using single-cell technologies","volume":"34","author":"Qin","year":"2024","journal-title":"Trends. Cell Biol."},{"issue":"6713","key":"10.1016\/j.neo.2026.101344_bib0061","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk9217","article-title":"Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers","volume":"385","author":"Sundaram","year":"2024","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0062","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1038\/s41467-024-47280-x","article-title":"Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma","volume":"15","author":"Roehrig","year":"2024","journal-title":"Nat. Commun."},{"issue":"8069","key":"10.1016\/j.neo.2026.101344_bib0063","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41586-025-08973-5","article-title":"Oncogene aberrations drive medulloblastoma progression, not initiation","volume":"642","author":"Okonechnikov","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neo.2026.101344_bib0064","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41556-020-0514-z","article-title":"Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance","volume":"22","author":"Bi","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.neo.2026.101344_bib0065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.neo.2026.101344_bib0066","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2020.06.012","article-title":"Emergence of a high-plasticity cell state during lung cancer evolution","volume":"38","author":"Marjanovic","year":"2020","journal-title":"Cancer Cell"},{"issue":"8104","key":"10.1016\/j.neo.2026.101344_bib0067","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41586-025-09985-x","article-title":"Critical role for a high-plasticity cell state in lung cancer","volume":"651","author":"Chan","year":"2026","journal-title":"Nature"},{"issue":"8102","key":"10.1016\/j.neo.2026.101344_bib0068","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41586-025-09916-w","article-title":"MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance","volume":"650","author":"White","year":"2026","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0069","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccell.2025.10.010","article-title":"Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer","volume":"44","author":"Zhang","year":"2026","journal-title":"Cancer Cell"},{"issue":"8022","key":"10.1016\/j.neo.2026.101344_bib0070","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","article-title":"Cellular adaptation to cancer therapy along a resistance continuum","volume":"631","author":"Franca","year":"2024","journal-title":"Nature"},{"issue":"8047","key":"10.1016\/j.neo.2026.101344_bib0071","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","article-title":"Progressive plasticity during colorectal cancer metastasis","volume":"637","author":"Moorman","year":"2025","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neo.2026.101344_bib0072","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41422-025-01139-y","article-title":"A patient-derived organoid model captures fetal-like plasticity in colorectal cancer","volume":"35","author":"Xiong","year":"2025","journal-title":"Cell Res."},{"issue":"15","key":"10.1016\/j.neo.2026.101344_bib0073","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1158\/1078-0432.CCR-20-0414","article-title":"MTL-CEBPA, a small activating RNA therapeutic upregulating C\/EBP-alpha, in patients with advanced liver cancer: a first-in-human, multicenter, open-label, phase I trial","volume":"26","author":"Sarker","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"410","key":"10.1016\/j.neo.2026.101344_bib0074","doi-asserted-by":"crossref","first-page":"eaal4291","DOI":"10.1126\/scitranslmed.aal4291","article-title":"An anti-glypican 3\/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors","volume":"9","author":"Ishiguro","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s42003-024-06190-w","article-title":"Genome-wide CRISPR screens identify the YAP\/TEAD axis as a driver of persister cells in EGFR mutant lung cancer","volume":"7","author":"Pfeifer","year":"2024","journal-title":"Commun. Biol."},{"issue":"18","key":"10.1016\/j.neo.2026.101344_bib0076","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.devcel.2025.04.022","article-title":"Neurodevelopmental hijacking of oligodendrocyte lineage programs drives glioblastoma infiltration","volume":"60","author":"Wu","year":"2025","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0077","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","article-title":"A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma","volume":"187","author":"Pozniak","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101344_bib0078","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1038\/s41467-023-40994-4","article-title":"Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial","volume":"14","author":"Noviello","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neo.2026.101344_bib0079","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.neo.2026.101344_bib0080","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41588-024-01948-8","article-title":"Base editing screens define the genetic landscape of cancer drug resistance mechanisms","volume":"56","author":"Coelho","year":"2024","journal-title":"Nat. Genet."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:38:23Z","timestamp":1788262703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"alternative-id":["S1476558626000758"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101344","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmentally constrained plasticity as a therapeutic vulnerability in cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101344"}}